Join to View Full Profile
4500 San Pablo Road SJacksonville, FL 32224
Dr. Zhao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Yujie Zhao is an oncologist in Jacksonville, FL and is affiliated with multiple hospitals in the area, including Mayo Clinic Hospital in Florida and St. Vincent's Medical Center Southside. She received her medical degree from Beijing Medical University and has been in practice 23 years. She is experienced in Head and Neck cancer, Lung cancer and Thyroid cancer.
Education & Training
- Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 2008 - 2011
- Rutgers Health/Cooperman Barnabas Medical CenterResidency, Internal Medicine, 2005 - 2008
- Beijing Medical UniversityClass of 1994
Certifications & Licensure
- FL State Medical License 2019 - 2026
- IL State Medical License 2015 - 2023
- NY State Medical License 2011 - 2017
- NJ State Medical License 2008 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery Start of enrollment: 2011 Oct 26
- Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer Start of enrollment: 2013 May 08
- An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) Start of enrollment: 2014 Mar 27
- Join now to see all
Publications & Presentations
PubMed
- Targeting Lung Cancer with Precision: The ADC Therapeutic Revolution.Reema Kamal Tawfiq, Guilherme Sacchi de Camargo Correia, Shenduo Li, Yujie Zhao, Yanyan Lou
Current Oncology Reports. 2025-04-16 - Osimertinib and Cardiotoxicity: A Topic to Keep Addressing.Shenduo Li, Rami Manochakian, Yujie Zhao, Yanyan Lou
Journal of Thoracic Oncology. 2025-02-01 - 1 citationsEmerging Immunotherapies for Advanced Non-Small-Cell Lung Cancer.Emily Wolf, Guilherme Sacchi de Camargo Correia, Shenduo Li, Yujie Zhao, Rami Manochakian
Vaccines. 2025-01-27
Authored Content
- Patient referralJanuary 2022
- Provider ProfileJanuary 2022
Press Mentions
- Medical Oncology Enhances Comprehensive Care Options for Patients with Head and Neck CancerJanuary 16th, 2025
- New Data Showing That Transgene and NEC’s Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses Against Tumors Presented at AACR 2023April 18th, 2023
- Transgene Presented Additional Phase I Data with TG4050 (Myvac® Platform) at ASCO 2022June 6th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
